Harry L. Anderson completed his PhD on ‘Model Enzymes Based on Porphyrins’ with Jeremy Sanders in 1990 at the University of Cambridge UK. He carried out postdoctoral work with François Diederich at ETH Zurich, Switzerland, on synthetic approaches to new carbon allotropes. He has led an independent research group at the University of Oxford since 1995. His work includes the investigation of porphyrin-based molecular wires, cyclodextrin polyrotaxanes, insulated molecular wires, encapsulated π-systems, template-directed synthesis, multivalent cooperativity, porphyrin nanorings, polyynes, cyclocarbons, nonlinear optical chromophores and functional dyes. Recent highlights from his research group include the AFM imaging of C₁₆ and C₁₈ (in collaboration with IBM Zurich), and the demonstration that a large porphyrin nanorings can exhibit an global aromatic ring currents.

Website: http://hla.chem.ox.ac.uk/

Rafal Klajn completed his undergraduate education and an MSc in Chemistry at the University of Warsaw in 2004. In 2009 he obtained a PhD degree in Chemical & Biological Engineering at Northwestern University. He then joined the Weizmann Institute of Science (WIS) as a tenure-track assistant professor. In 2016, he was promoted to associate professor and to full professor in 2020. Since 2017, he also served as the director of the Helen and Martin Kimmel Center for Molecular Design. Since August 2023, the Klajn group has been based at the Institute of Science and Technology Austria (ISTA). Klajn has served on the boards of several journals, including Chem, ACS Nano, and ChemSystemsChem, and received several awards, including the Netherlands Scholar Award for Supramolecular Chemistry, the Cram Lehn Pedersen Prize in Supramolecular Chemistry, and the Sigma-Aldrich lectureship in Materials Science.

Dr. Daniel Maspoch is an ICREA Research Professor and Leader of the Supramolecular NanoChemistry & Materials Group at ICN2. He is a chemist who has always maintained a rewarding balance between fundamental and applied research, with pioneering developments in the field of porous metal-organic frameworks and delivery systems. He is author of over 190 manuscripts. In 2021 and 2022, he got the prestigious ERC Advanced Grant and a second ERC Proof-of-Concept Grant, respectively. In addition, he was awarded an ERC Consolidator Grant in 2014, and his first ERC Proof-of-Concept Grant in 2019. In 2015, he was awarded the Premio Marcial Moreno Mañas Lectureship, in 2020 he was rewarded with the Research Excellence Award from the Spanish Royal Society of Chemistry, and in 2022 he was appointed new Corresponding Academician of the Physical and Chemical Sciences Section, in the specialty of Materials Science by the Royal Spanish Academy of Science (RAC). Finally, in 2023, he was awarded the Rei Jaume I Award in New Technologies.
From the technology transfer side, several technologies and materials developed by his group have been transferred –through licensing patents or signing technology transfer contracts– to various companies. More specifically, Daniel has signed more than 23 research contracts with private companies and has filed 12 patents, from which 4 have been licensed. Moreover, he has been able to signed 4 technology transfer contracts. Interestingly, these technologies have given rise to families of products that are now on the market, as for example LuctaCaps® and Fungipol@CP. He is also co-founder of the spin-off company Ahead Therapeutics.

Jonathan Nitschke received his bachelor's degree from Williams College (USA) in 1995 and his doctorate from the University of California, Berkeley in 2001 under the supervision of T. Don Tilley. He then undertook postdoctoral studies with Jean-Marie Lehn in Strasbourg under the auspices of a US NSF fellowship, and in 2003 he started his independent research career as a Maître-assistant (non-tenured PI) in the Organic Chemistry Department of the University of Geneva. In 2007 he was appointed University Lecturer at Cambridge, where he now holds a Professorship. He is the recipient of the Izatt-Christensen Award in Supramolecular chemistry (2022), a Wolfson Research Merit Award of the UK Royal Society (2017), the International Award for Creative Work of the Japan Society of Coordination Chemistry (2016), the Bob Hay Lectureship of the Royal Society of Chemistry (2013), the Cram Lehn Pedersen Prize in Supramolecular Chemistry (2012), the Corday-Morgan Prize of the Royal Society of Chemistry (2011), the Dalton Transactions European/African Lectureship (2011), the Werner Prize of the Swiss Chemical Society (2007) and the European Young Chemist Award at the first EuCheMS Congress (2006). His research program investigates the self-assembly of complex, functional structures from simple molecular precursors and metal ions.

Lluïsa Pérez-García completed her PhD in Medicinal Chemistry at the Universitat de Barcelona (UB). After a two-year postdoctoral stay at the University of Birmingham (UK), in Fraser Stoddart`s group, she moved to the School of Pharmacy at the UB where she gained a post as tenured lecturer and then became an Associate Professor in the Organic Chemistry Laboratory of the School Pharmacy (1997). In the academic year 2015-16 she spent a sabbatical year at the University of Nottingham (UoN). After obtaining a research leave from UB, in 2017 she was appointed for 2 years as an Anne McLaren Research fellow at the School of Pharmacy, UoN, where she became Associate Professor until October 2020, and where she still holds an honorary associate position. In March 2020 she gained a full professorship at the UB, where she is now a full-time professor since November 2020.
Her research experience is in synthetic, structural, medicinal and supramolecular chemistries. Her current interests are mainly in the field of nanobiomedicine and include the use of nanoparticles and hydrogels for drug delivery of anticancer agents, especially using photodynamic therapy, and the bio-functionalization of suspended chips to study, tag and actuate inside living cells. She is also interested in molecular machines that induce molecular movement on surfaces.
She leads the research group Supramolecular systems for Nanobiomedicine, a member of the IN2UB, and she also leads the consolidated research group Photo- and electroresponsive micro-and nanostructured functional materials, recognised by the Generalitat de Catalunya.

Konrad received his chemical basic education at the Technical University of Vienna and the University of Texas in Austin. After finishing his diploma thesis in the lab of Prof. Fröhlich, he pursued his interest in total synthesis of biologically active natural products during a Ph.D. in the lab of Prof. Mulzer at the University of Vienna. He then moved to Prof. Rebek’s lab at The Scripps Research Institute in La Jolla to learn about molecular recognition and self-assembly. In 2012 he started his independent career as a Junior professor (W1-position) at the Technical University Munich. In June 2016 he was appointed to a dual tenure track assistant professorship position at the University of Basel and the ETH Zürich, and received tenure in 2020.

https://nanocat.chemie.unibas.ch/en/
twitter: @TiefenbacherLab